Delivery Order SPE2DB25D3020-SPE2DB25FWFXZ
Award Date
2/12/25
Potential Completion Date
2/13/25
Potential Value
$8.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ORENCIA 250 MG VIALS to the Defense Logistics Agency (DLA) Troop Support Medical. The $10,781.94 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 8, 2024 and was awarded on March 7, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $10,978.57 in Firm Fixed Price delivery orders for ORENCIA 125 MG/ML SYRINGE/ML medical supplies. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and runs through January 10, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,249.72, is for the delivery of ORENCIA 125 MG/ML SYRINGEML, a medical product, under a Firm Fixed Price Delivery Order contract. The contract has an ultimate completion date of April 4, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award is for the delivery of ORENCIA 125 MG/ML SYRINGEML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The fixed-price delivery order, valued at $26,483.23, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of ORENCIA 125 mg/mL syringes to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $12,043.68. The contract has an ultimate completion date of July 9, 2024 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the delivery of ORENCIA 125 MG/ML SYRINGEML. The $21,118.16 firm fixed price delivery order contract has a period of performance through May 9, 2023 and was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,677.56 firm-fixed-price delivery order is for the supply of ORENCIA 125 MG/ML syringes. The contract has an ultimate completion date of October 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
The U.S. Defense Logistics Agency (DLA) awarded a $8,222.34 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4566747930 - ORENCIA 125 MG/ML SYRINGEML. This contract has an ultimate completion date of December 18, 2024. Amerisourcebergen is not subject to any set-aside requirements for this award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,154.08 firm fixed-price delivery order is for the supply of ORENCIA 125 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of December 4, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,512.01, is a delivery order for 4563249270 - ORENCIA 125 MG/ML SYRINGEML, with a performance period ending on January 8, 2024. The contract is a firm fixed-price arrangement and does not have any set-aside designation. Amerisourcebergen holds a significant Indefinite...